US - During the 2015 World Pork Expo in Des Moines, Iowa, veterinarians from two leading swine health and production companies shared their recommendations on how producers can best manage their herds for profitability during tough times.
MEXICO - Innovative swine health solutions to improve pig health and optimize pig production will be the key focus of the Boehringer Ingelheim IPVS Symposium 2014.
Leading swine veterinarians address overall vaccination compliance issues critical to effectively managing Mycoplasma hyopneumoniae and porcine circovirus in the latest At the Meeting (ATM) programme, produced by Dr Bob Morrison, University of Minnesota.
Boehringer Ingelheim Animal Health has decided to remain focused on freshly mixed Porcine Circovirus type 2 (PCV2)/ Mycoplasma hyopneumoniae (M.hyo) vaccines and not follow the development of a PCV2/M.hyo ready-to-use (RTU) vaccine combination. As a consequence of this decision, the company has discontinued its PCV2/M.hyo RTU research program.
Animal welfare is becoming an extremely important consideration in pig rearing. The safety of vaccines is an important factor in this. Stressful treatments have negative impact on weight gain. Careful observation is essential and can make all the difference:
Read and download the posters.
Get the latest news on Swine Health Subscribe to our newsletter